1
|
Tsoukalas N, Tsapakidis K, Tolia M, Kiakou M, Galanopoulos M, Aravantinou-Fatorou E, Baxevanos P, Papadopoulos V, Tountziaris C, Nikolaou M, Kamposioras K. Pseudomyxoma Peritonei: A Challenging Clinical Diagnosis. Case Report and Review of the Literature. Cancer Diagn Progn 2024; 4:198-203. [PMID: 38434922 PMCID: PMC10905292 DOI: 10.21873/cdp.10308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 09/13/2023] [Accepted: 11/29/2023] [Indexed: 03/05/2024]
Abstract
Background Pseudomyxoma peritonei (PMP) is a clinical entity of subtle onset abdominal pain, ascites, and distention associated with characteristic imaging. In most cases, laparoscopic exploration will give the definitive diagnosis and histopathologic verification. However, usually there are difficulties in the diagnosis of this disease. Case Report Herein, we present a case of a 51-year-old female who developed ascites over 5 months. An investigational laparotomy established the diagnosis of PMP, after the discovery of a mucinous, grey-brown tumor that was CK20 positive and CK7 negative. Subsequently, chemotherapy with oxaliplatin combined with 5-FU (FOLFOX4 regimen), was initiated and the patient survived for 30 months. We also present a comprehensive review of the English literature concerning the different symptoms and radiological findings of this rare entity. According to the literature review, 35 cases of PMP with different clinical and radiological findings have been described. In the majority of the cases, ultrasound, computed tomography or magnetic resonance imaging was orientating towards a proper diagnosis before a diagnostic laparotomy. Conclusion The combination of a clinical picture with the characteristic imaging findings enables a prompt diagnosis of PMP, making prognosis more favorable.
Collapse
Affiliation(s)
- Nikolaos Tsoukalas
- Department of Oncology, 401 General Military Hospital of Athens, Athens, Greece
| | | | - Maria Tolia
- Department of Radiotherapy, Faculty of Medicine, School of Health Sciences, University of Crete, Heraklion, Greece
| | - Maria Kiakou
- Department of Oncology, 401 General Military Hospital of Athens, Athens, Greece
| | | | | | | | | | | | - Michalis Nikolaou
- Department of Oncology, 401 General Military Hospital of Athens, Athens, Greece
| | | |
Collapse
|
2
|
Tsoukalas N, Kiakou M, Tolia M, Galanopoulos M, Tsapakidis K, Arvanitou E, Charalambakis N, Tountziaris V, Nikolaou M, Christofyllakis C. SYNCHRONOUS DIAGNOSIS OF TESTICULAR AND THYROID CANCER IN A YOUNG MALE. Exp Oncol 2023; 45:263-268. [PMID: 37824765 DOI: 10.15407/exp-oncology.2023.02.263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Indexed: 10/14/2023]
Abstract
Testicular cancer is the most common neoplasm in young males. The early diagnosis and the appropriate treatment make it a curable malignancy in over 90% of the patients, but 6% of the patients with testicular cancer develop a second, mostly treatment-related, malignancy in another primary site many years after the first diagnosis. The simultaneous appearance of a testicular tumor with another primary neoplasm is rarely described in the literature. Here is presented an interesting case of a coexisting non-seminomatous germ cell testicular tumor with a papillary thyroid carcinoma, which was detected early during post-treatment restaging of the testicular tumor. The synchronous presence of these two neoplasms might indicate a probable common pathogenetic background. As treatment-related oncogenesis is highly improbable in this case and the common environmental factors are not known yet, the interest is focused on genetic predisposition. Recent discoveries in molecular genetics show that the two neoplasms share common genetic alterations in the RAS and BRAF genes, which affect the significant signaling pathways. Interestingly, BRAF-V600E was positive in both primary malignancies in our individual.
Collapse
Affiliation(s)
- N Tsoukalas
- 401 General Military Hospital, Athens 11524, Greece
| | - M Kiakou
- 401 General Military Hospital, Athens 11524, Greece
| | - M Tolia
- Department of Radiotherapy-Radiation Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
| | | | - K Tsapakidis
- Department of Radiotherapy-Radiation Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
| | - E Arvanitou
- 401 General Military Hospital, Athens 11524, Greece
| | - N Charalambakis
- Department of Medical Oncology, Metaxa Cancer Hospital, Piraeus, Greece
| | - V Tountziaris
- 1st Urological Department, Aristotle University of Thessaloniki, Greece
| | - M Nikolaou
- 1st Oncology Department, Anti-cancer Hospital "Sant Savvas", Athens, Greece
| | | |
Collapse
|
3
|
Kiakou M, Tolia M, Koufopoulos N, Tsapakidis K, Arvanitou E, Konstantinos G, Charalambakis N, Nikolaou M, Matthaios D, Tsoukalas N. A Rare Case of Primary Carcinosarcoma of the Breast. Forum of Clinical Oncology 2023. [DOI: 10.2478/fco-2022-0006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/29/2023] Open
Abstract
Abstract
Breast carcinosarcoma is a rare malignancy accounting for approximately 0.08–0.2% of all breast tumours. It is a type of metaplastic mammary carcinoma displaying biphasic differentiation with epithelial and mesenchymal cellular characteristics with probable derivation from myoepithelial cells.
A 65-year-old woman presented to our hospital with a two-month history of a rapidly growing mass in her left breast. Neither her medical nor family history was positive for malignancies. Subsequently, she underwent a fine needle aspiration, which was positive for adenocarcinoma, followed by a lumpectomy with axillary lymph node dissection. The histology revealed an undifferentiated neoplasm and the immunohistochemical cell staining was positive for pan-cytokeratin, SMA, Vimentin, and S-100, suggesting the diagnosis of breast carcinosarcoma with a triple-negative immunophenotype. There was no evidence of metastasis except for a positive lymph node, indicating a stage IIIA disease. Thus, she received adjuvant chemo-radiotherapy. However, 16 months later, she presented with metastatic disease, and unfortunately, she died 4 months later due to a systemic infection.
Aggressive behavior, higher staging, chemoresistance, and higher proportion of triple negative breast cancer seem to be the main characteristics of breast carcinosarcoma, which is recognised as a separate entity from common invasive ductal carcinoma, with significantly worse clinical outcomes.
Collapse
|
4
|
Kiakou M, Puvanendran M, Philpott J, Ali A, Paulucci B. Laryngeal solitary fibrous tumour: diagnostic challenge in a rare presentation. Ann R Coll Surg Engl 2022; 104:e219-e225. [PMID: 35446174 PMCID: PMC9246558 DOI: 10.1308/rcsann.2021.0332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Solitary fibrous tumours (SFT) are rare spindle cell mesenchymal neoplasms, most commonly appearing as well-circumscribed localised lesions arising from the abdominal or pelvic peritoneum. Their presence in the head and neck region is very rare; even more so in the post-cricoid region, with only one case described in the literature to date. The clinical behaviour of SFT may vary from benign to malignant, but only 10-15% of SFT demonstrate local recurrence or distant metastasis. The usual presenting symptoms of dysphagia and weight loss are very vague to give a definite diagnosis, and examination, even under general anaesthesia, combined with biopsies can sometimes be misleading, as in our case. Here, we describe a very challenging case of supraglottic SFT originating from the post-cricoid area. Our 73-year-old patient presented with dysphagia and upon examination a large supraglottic mass was revealed. Biopsies from the mass pointed to malignancy and the patient underwent total laryngectomy. The laryngeal specimen contradicted the biopsy and revealed a rare solitary fibrous tumour with benign features and thus adjuvant treatment was not necessary. Ever since the patient has been attending regular follow-up sessions and remains disease-free 18 months after surgery.
Collapse
Affiliation(s)
- M Kiakou
- Mid and South Essex NHS Foundation Trust, UK
| | | | - J Philpott
- Mid and South Essex NHS Foundation Trust, UK
| | - A Ali
- Mid and South Essex NHS Foundation Trust, UK
| | - B Paulucci
- The Princess Alexandra Hospital NHS Trust, UK
| |
Collapse
|
5
|
Wong BLK, Kiakou M. Soft Palate Ulcer-Benign or Malignant? JAMA Otolaryngol Head Neck Surg 2021; 147:901-902. [PMID: 34383030 DOI: 10.1001/jamaoto.2021.1927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Affiliation(s)
- Billy L K Wong
- Department of Otolaryngology-Head and Neck Surgery, Broomfield Hospital, Essex, United Kingdom
| | - Maria Kiakou
- Department of Otolaryngology-Head and Neck Surgery, Broomfield Hospital, Essex, United Kingdom
| |
Collapse
|
6
|
Tsoukalas N, Giaginis C, Alexandrou P, Liontos M, Tolia M, Kiakou M, Sfiniadakis I, Kavantzas N, Patsouris E, Theocharis S. 1995P Clinical significance of cannabinoid receptor CB2 expression in non-small cell lung cancer (NSCLC). Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
7
|
Tsoukalas N, Kiakou M, Nakos G, Tolia M, Galanopoulos M, Tsapakidis K, Kamposioras K, Christofyllakis C, Dimitrakopoulos G, Sambaziotis D. Desmoplastic small round-cell tumour of the peritoneal cavity: case report and literature review. Ann R Coll Surg Engl 2020; 102:e77-e81. [PMID: 31973562 DOI: 10.1308/rcsann.2019.0180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Desmoplastic small round-cell tumour is a very rare neoplasm, which usually arises from the abdominal or pelvic peritoneum of adolescents and young adults. Early diagnosis is difficult, because most tumours present with non-specific gastrointestinal symptoms after a long asymptomatic period. It is generally a very aggressive tumour, which grows rapidly with poor prognosis and an overall five-year survival rate of 15% despite multimodal treatment. Despite multiple treatment strategies, the management of desmoplastic small round-cell tumour still remains a clinical challenge and no consensus about a therapeutic protocol has been established. A 35-year-old man presented with mild abdominal pain, constipation and weight gain, and was eventually diagnosed with desmoplastic small round-cell tumour, which was shown to be limited to the abdomen. After incomplete debulking surgery, radiotherapy and chemotherapy, he developed multiple metastatic nodular foci in chest and the pleura and, unfortunately, he died due to disease progression.
Collapse
Affiliation(s)
- N Tsoukalas
- Department of Oncology, Veterans Hospital (NIMTS), Athens, Greece
| | - M Kiakou
- Department of Oncology, Veterans Hospital (NIMTS), Athens, Greece
| | - G Nakos
- 401 General Military Hospital, Athens, Greece
| | - M Tolia
- Department of Radiotherapy-Radiation Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
| | - M Galanopoulos
- Department of Oncology, Veterans Hospital (NIMTS), Athens, Greece
| | - K Tsapakidis
- Department of Oncology, Veterans Hospital (NIMTS), Athens, Greece
| | - K Kamposioras
- Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom
| | | | | | | |
Collapse
|
8
|
Tsoukalas N, Kiakou M, Tsapakidis K, Tolia M, Aravantinou-Fatorou E, Baxevanos P, Kyrgias G, Theocharis S. PD-1 and PD-L1 as immunotherapy targets and biomarkers in non-small cell lung cancer. J BUON 2019; 24:883-888. [PMID: 31424637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
The integration of immunotherapeutic agents in the treatment of non-small cell lung cancer (NSCLC) has revolutionized the approach of the prevalent type of lung cancer. Although PD-1 and its ligands (PD-L1 and PD-L2) are stimulating molecules of the immune-checkpoint pathway, with primary function to limit inflammatory response and autoimmunity, tumor cells have found a way to exploit these molecules by obtaining the opportunity to respond with PD-L1 expression in cytokine signals and thus to evade immune surveillance. Several immunotherapeutic agents targeting these molecules have already been tested and show quick and remarkable responses and survival prolongation in about 14-20% of chemo-resistant patients in NSCLC, resulting to FDA approval of some PD-1 inhibitors (pebrolizumab, nivolumab), even for first-line treatment of patients with metastatic NSCLC whose tumors have high PD-L1 expression (pebrolizumab). Regarding to the prognostic value of PD-L1 and PD-1 expression as biomarkers in NSCLC, the results still remain contradictory. However, the elevated expression of PD-L1 has been correlated with higher efficacy of the various immunotherapeutic agents, implying a high predictive value of this biomarker, even if the truth about specificity and sensitivity of the aforementioned molecules is generally more complicated.
Collapse
|
9
|
Tsoukalas N, Aravantinou E, Tsapakidis K, Giaginis C, Tolia M, Binas I, Baxevanos P, Galanopoulos M, Kiakou M, Kostakis I, Nikolaou C, Litos I, Liontos M, Tsiambas E, Gioulbasanis I, Sfiniadakis I, Karameris A, Kyrgias G, Theocharis S, Tsiatas M. Clinical significance of RCAS1 and CD3 expression in non-small cell lung cancers in immunotherapy era. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy269.174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
10
|
Tsoukalas N, Kiakou M, Tolia M, Kostakis ID, Galanopoulos M, Nakos G, Tryfonopoulos D, Kyrgias G, Koumakis G. Mucinous breast carcinoma with tall columnar cells. Ann R Coll Surg Engl 2018; 100:e132-e135. [PMID: 29658333 DOI: 10.1308/rcsann.2018.0060] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Mucinous carcinoma of the breast represents 1%-4% of all breast cancers. The World Health Organization classification divides this type of tumour into three different subtypes: mucinous carcinoma, mucinous carcinoma with tall columnar cells (mucinous cystadenocarcinoma and columnar cell mucinous carcinoma) and signet ring cell carcinoma. A 74-year-old woman presented a tumour with inflammatory features in the upper outer quadrant of her left breast, 7 cm in diameter. The core biopsy showed infiltrating ductal carcinoma of no specific type. The tumour-node-metastasis clinical staging was T4cN3M0 (Stage IIIC). She received neoadjuvant chemotherapy, underwent left mastectomy with radical axillary resection and subsequently received radiotherapy and chemotherapy. The histological examination of the surgical specimen revealed two solid tumors in the tail of Spence, which corresponded to adenocarcinoma with high columnar cells. The patient died 16 months after the diagnosis, suffering from pulmonary metastases and anterior chest wall infiltration. A review of the literature revealed only 21 reports of mucinous carcinoma of the breast with tall columnar cells, including our case. This is only the third time that the specific histological type of columnar cell mucinous carcinoma has been reported in the literature.
Collapse
Affiliation(s)
- N Tsoukalas
- Department of Oncology, 401 General Military Hospital , Athens , Greece.,Second Department of Medical Oncology, Agios Savvas Anticancer Hospital , Athens , Greece.,Contributed equally
| | - M Kiakou
- Department of Oncology, 401 General Military Hospital , Athens , Greece.,Contributed equally
| | - M Tolia
- Department of Radiotherapy, University of Thessaly, Medical School , Larissa , Greece
| | - I D Kostakis
- Second Department of Propedeutic Surgery, Laiko General Hospital, National and Kapodistrian University of Athens, Medical School , Athens , Greece
| | - M Galanopoulos
- Department of Oncology, 401 General Military Hospital , Athens , Greece
| | - G Nakos
- Department of Pathology, 401 General Military Hospital , Athens , Greece
| | - D Tryfonopoulos
- Second Department of Medical Oncology, Agios Savvas Anticancer Hospital , Athens , Greece
| | - G Kyrgias
- Department of Radiotherapy, University of Thessaly, Medical School , Larissa , Greece
| | - G Koumakis
- Second Department of Medical Oncology, Agios Savvas Anticancer Hospital , Athens , Greece
| |
Collapse
|
11
|
Sahsamanis G, Terzoglou A, Theodoridis C, Kiakou M, Mitsopoulos G, Deverakis T, Dimitrakopoulos G. Laparoscopic repair of an excessive Morgagni hernia in an adult presenting as upside-down stomach. Int J Surg Case Rep 2018; 41:443-445. [PMID: 29546012 PMCID: PMC5702857 DOI: 10.1016/j.ijscr.2017.11.014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2017] [Revised: 11/03/2017] [Accepted: 11/06/2017] [Indexed: 11/25/2022] Open
Abstract
Morgagni hernias represents a rare subtype of diaphragmatic congenital hernias manifesting usually during early childhood. An innocuous or asymptomatic presentation render diagnosis of Morgagni hernias a challenging procedure. In our case, an adult female patient presented with a giant Morgagni hernia, initially diagnosed as a paraesophageal hernia. Early treatment of such cases is advised due to potential fatal complications. Laparoscopic surgery is considered the best approach.
Introduction Morgagni hernia is defined as the intrathoracic protrusion of abdominal viscera through a defect in the anterior diaphragm. It represents an uncommon type of diaphragmatic congenital hernia. Case presentation A 68-year-old female patient was admitted in our department due to progressive epigastric discomfort for the past four months. A preoperative diagnosis of a paraesophageal hernia was set through computer tomography, with gastric portions and parts of small bowel protruding inside the thoracic cavity. Intraoperatively, an excessive diaphragmatic defect was detected in the anterior side of the diaphragm. Reduction of the hernia’s contents inside the abdominal cavity was achieved through laparoscopy, with the additional fixation of an intraperitoneal non-absorbable mesh for reinforcement of the diaphragmatic wall. Patient was discharged uneventfully on the 4th postoperative day. Discussion Morgagni hernias refer to a rare type of diaphragmatic congenital hernias, usually identified during childhood, leaving only a small number of cases observed in the adult population. Its diagnosis can pose a challenge due to the non-specific and usually asymptomatic presentation. An early surgical management is advised due to an increased number of potentially lethal complications, such as gastric incarceration and obstruction. Treatment consist of open surgical techniques through a trans-thoracic or a trans-abdominal approach, although a paradigm shift in the 21st century considers minimal invasive laparoscopic surgery the treatment of choice. Conclussion A high index of clinical suspicion is required for diagnosis of Morgagni hernias, while prompt management is advised. Laparoscopy is considered the best approach in the hands of an experienced surgeon.
Collapse
Affiliation(s)
| | | | | | - Maria Kiakou
- 1st Department of Surgery, 401 Army General Hospital of Athens, Greece
| | | | - Titos Deverakis
- 1st Department of Surgery, 401 Army General Hospital of Athens, Greece
| | | |
Collapse
|
12
|
Tsoukalas N, Kostakis ID, Giaginis C, Tolia M, Galanopoulos M, Kiakou M, Aravantinou-Fatorou E, Tsapakidis K, Baxevanos P, Litos I, Tzouda V, Tzovaras A, Kyrgias G, Tsiambas E, Theocharis S. Carcinoembryonic antigen and carbohydrate antigen 19-9 serum levels in non-small cell lung cancer. J BUON 2017; 22:1390-1394. [PMID: 29332328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
PURPOSE Τo investigate the potential diagnostic and prognostic role of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) serum levels in non-small cell lung cancer (NSCLC). METHODS One hundred consecutive patients with newly diagnosed primary NSCLC were included in this study (88 men and 12 women). Blood was drawn before any kind of treatment and the collected serum was processed using chemiluminescence in order CEA and CA 19-9 levels to be measured. RESULTS No significant associations between CEA or CA 19-9 levels and any tested clinical and pathological parameter were detected. Moreover, CEA levels did not seem to affect survival. On the other hand, patients with high CA 19-9 values (≥37 IU/ml) (median survival: 8 months) had a shorter overall survival than patients with low CA 19-9 values (<37 IU/ml) (median survival: 13 months) (p=0.026). However, CA 19-9 levels did not remain an independent prognostic factor in the multivariate survival analysis (p=0.114). CONCLUSION CEA and CA 19-9 serum levels do not seem to have any diagnostic role in NSCLC. With regard to their prognostic role, CEA values do not seem to affect the prognosis in NSCLC. However, high CA 19-9 values are associated with worse prognosis.
Collapse
|
13
|
Tsapakidis K, Tsoukalas N, Giaginis C, Gioulbasanis I, Tolia M, Aravantinou E, Galanopoulos M, Kiakou M, Kostakis I, Litos I, Liontos M, Sogka E, Tzouda V, Liaskonis K, Theocharis S. Systematic inflammation and histologic grade in non-small cell lung carcinoma. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
14
|
Tsoukalas N, Aravantinou-Fatorou E, Tolia M, Giaginis C, Galanopoulos M, Kiakou M, Kostakis ID, Dana E, Vamvakaris I, Korogiannos A, Tsiambas E, Salemis N, Kyrgias G, Karameris A, Theocharis S. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer. Anticancer Res 2017; 37:1773-1778. [PMID: 28373440 DOI: 10.21873/anticanres.11510] [Citation(s) in RCA: 50] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2017] [Revised: 03/20/2017] [Accepted: 03/21/2017] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM Lung cancer is the first cause of cancer related deaths in both males and females. Epithelial-mesenchymal transition (EMT) is a reversible process by which epithelial cells transform to mesenchymal stem cells by losing their cell polarity and cell-to-cell adhesion, gaining migratory and invasive properties. High levels of E-cadherin are expressed in epithelial cells, whereas mesenchymal cells express high levels of N-cadherin, fibronectin and vimentin. The aim of this study was to evaluate the correlation between E-cadherin and vimentin expression and their clinical significance in non-small cell lung cancer (NSCLC). MATERIALS AND METHODS The immunohistochemical expression of E-cadherin, vimentin and Ki-67 was performed on tissue microarrays from NSCLC specimens obtained from 112 newly- diagnosed cases and were studied using classical pathological evaluation. Associations between E-cadherin, vimentin and Ki-67 expression, clinicopathological variables and survival were analyzed. In all cases, a value of p≤0.05 was considered significant. RESULTS Low E-cadherin expression was significantly correlated with tumor necrosis (p=0.019). Moreover, there was a trend for correlation between high E-cadherin expression and better overall survival (hazard ratio=1.02, and 95% confidence interval=0.45-1.87, p=0.091). There was also a significant negative correlation between vimentin expression and overall survival (hazard ratio=1.13, and 95% confidence interval=0.78-1.65, p=0.026). Additionally, there was a significant negative correlation between vimentin expression and grade I tumors (p=0.031). Finally, a positive correlation trend between vimentin expression and Ki-67 was found (p=0.073). CONCLUSION High E-cadherin and low vimentin expression correlate with better prognosis and overall survival.
Collapse
Affiliation(s)
| | | | - Maria Tolia
- Department of Radiotherapy-Radiation Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
| | | | | | | | | | - Eugene Dana
- First Department of Pathology, Medical School, University of Athens, Athens, Greece
| | - Ioannis Vamvakaris
- First Department of Pathology, Medical School, University of Athens, Athens, Greece
| | | | | | | | - George Kyrgias
- Department of Radiotherapy-Radiation Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
| | | | - Stamatios Theocharis
- First Department of Pathology, Medical School, University of Athens, Athens, Greece
| |
Collapse
|
15
|
Tsoukalas N, Galanopoulos M, Tolia M, Kiakou M, Nakos G, Papakostidi A, Koumakis G. Rectal neuroendocrine tumor with uncommon metastatic spread: A case report and review of literature. World J Gastrointest Oncol 2016; 8:231-234. [PMID: 26909138 PMCID: PMC4753174 DOI: 10.4251/wjgo.v8.i2.231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/05/2015] [Revised: 11/06/2015] [Accepted: 12/08/2015] [Indexed: 02/05/2023] Open
Abstract
Neuroendocrine tumors of the gastrointestinal tract are rare neoplasms. Rectal neuroendocrine tumors consist approximately the 5%-14% of all neuroendocrine neoplasms in Europe. These tumors are diagnosed in relatively young patients, with a mean age at diagnosis of 56 years. Distant metastases from rectal neuroendocrine tumors are not very common. Herein we describe a case of a rectal neuroendocrine tumor which metastasized to the lung, mediastinum and orbit. This case underscores the importance of early identification and optimal management to improve patient’s prognosis. Therefore, the clinical significance of this case is the necessity of physicians’ awareness and education regarding neuroendocrine tumors’ diagnosis and management.
Collapse
|